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Abstract 
Background: our aim was to assess frequency of asymptomatic sacroiliitis (SI) in patients with Crohns 
disease referred for magnetic resonant enterography (MRE) as a part of small bowel evaluation.  
Methods: this was a retrospective study of all patients with Crohns disease who were referred for MRE 
between January of 2016 to October of 2017 to Jordan University Hospital. All MRE were reviewed by 
an experienced radiologist and SI was diagnosed and graded based on predefined MRI criteria. All 
patients were contacted and assessed for symptomatic SI based on Assessment of SpondyloArthritis 
international Society (ASAS) criteria of 2009 for axial spondyloarthropathy. All patients were included 
in the final analysis. 
Results: a total of 60 patients were included, overall 18 (30%) showed evidence of SI, two patients 
were symptomatic and another two were diagnosed with ankylosing spondylitis as assessed by ASAS 
criteria. Those were excluded. Fourteen (23%) patients were included in the final analysis, with an 
average age of 36.7 years, 71% males. The average disease duration was 7.25 years. The percentage of 
ASA used by patients was 50%, Azathioprine 71%, Biologic agents in 36% in combination and single 
drug was used in 36% of patients. 
Conclusion: The prevalence of asymptomatic SI based on predefined MRI criteria was 23%, the 
importance of this finding and future course progression needs further studies. 
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1. Introduction 
Extra-intestinal musculoskeletal manifestations associated with Inflammatory bowel disease (IBD), can 
be divided into axial and peripheral arthropathy, which can be a cause of significant morbidity that can 
adversely affect the quality of life in these patients. Peripheral arthropathy represent the most frequent 
(40%) extra-intestinal manifestation in IBD (Gravallese & Kantrowitz, 1988; Vavricka, Schoepfer, 
Scharl, Lakatos, Navarini, & Rogler, 2015). These manifestations occur more frequently in patients 
with Crohn’s disease (CD) (Veloso, Carvalho, & Magro, 1996). Sacroiliitis (SI) is considered one of the 
common axial arthropathies with an estimated prevalence of around 10% of Crohn’s patients (Maren, 
Jolanda, Johanna, & Angelique, 2017). The diagnosis is based upon the presence of characteristic 
inflammatory type back pain with evidence of SI on imaging (Sieper et al., 2009). Both clinical 
examination and plain radiographs have their own limitations of only detecting advanced disease. CT 
enterography is a more sensitive technique to assess SI joint, a frequent radiologic study in patients 
with CD to assess small bowel disease, but its major drawback is the risk of radiation exposure. MRI is 
a promising technology with a higher sensitivity and specificity for the diagnosis of SI. As MRI is 
being utilized more frequently in patients with Crohn’s disease, more and more patients are found to 
have a positive MRI evidence of SI without clinical signs or symptoms. Limited number of 
publications have utilized MRI for the diagnosis of asymptomatic SI in patients with CD. The 
prevalence and clinical significance of such finding on MRI is currently unclear at this time and 
whither these patients may progress to symptomatic disease needs to be determined.  
The aim of this study is to assess the frequency of asymptomatic sacroiliitis in Jordanian Crohn’s 
patients based on predefined MRI criteria. 
 
2. Methods 
This is a retrospective study for all patients with CD who underwent Magnetic Resonance Enteroclysis 
(MRE) at Jordan university hospital to evaluate their small bowel as part of disease extent work up at 
the discretion of the treating physician. The study was carried out between January 2016 and October 
2017. All cases were identified and included in the final analysis. All MREs were reviewed by an 
experienced radiologist. Table 1 summarizes the utilized MRE protocol.  
 













Voxel size/ mm time 
T2_haste 4.0mm coronal 25 30 1400 94 160 2,5 x 1.7 x 4.0 0:35 
T2_haste 4.0 transverse 40 30 1400 90 150 1.9 x 1.3 x 4.0  0:56 
T1_vibe 
Fat sat  
3:00 coronal 64 20 4.13 1.41 9.0 2:0 x 1.4 x 3,0  0:18 
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T1_vibe 
With contrast 
3:00 coronal 64 20 4.13 1.41 9.0 2.0 x 1.4 x 3.0 1.05 
T1_vibe 
With contrast 
3:00 transverse 40 20 4.23 1.46 9.0 1.7 x 1.2 x 3.0 0.12 
 
Electronic medical records were reviewed, those with the final diagnosis of IBD/Crohn’s (Made by a 
gastroenterologist) were selected and classified using the Montreal classification for clinical, molecular, 
and serological classification of inflammatory bowel disease, Table 2 (Silverberg et al., 2005; Satsangi, 
Silverberg, Vermeire, & Colombel, 2006).  
 
Table 2. Montreal Classification for Crohn’s Disease (Jaremko, Liu, Winn, Ellsworth, & Lambert, 
2014) 
Age at diagnosis  A1 below 16 y 
 A2 between 17 and 40 y 
 A3 above 40 y 
Location  L1 ileal 
 L2 colonic 
 L3 ileocolonic 
 L4 isolated upper disease* 
Behaviour  B1 non-stricturing, non-penetrating 
 B2 stricturing 
 B3 penetrating 
 p perianal disease modifier _ 
* L4 is a modifier that can be added to L1-L3 when concomitant upper gastrointestinal disease is 
present. 
“p” is added to B1-B3 when concomitant perianal disease is present. 
 
All patients with SI based on MRI criteria were contacted and assessed for symptomatic SI based on 
Assessment of SpondyloArthritis international Society (ASAS) criteria of 2009 for axial 
spondyloarthropathy. Although these criteria were based on plain radiography findings of structural 
damage such as sclerosis, erosions and ankylosis, MRI can detect bone marrow edema which is an 
earlier manifestation of the disease process in the form of one focus of subchondral or periarticular 
bone marrow edema on more than two slices or locations, or more than one focus on one slice Table 3 
(Sieper et al., 2009; Rudwaleit, 2009; Jaremko, Liu, Winn, Ellsworth, & Lambert, 2014). 
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Table 3. New York Sacroiliitis Radiological Grading Criteria (Sudoł-Szopińska, Kwiatkowska, 
Włodkowska-Korytkowska, Matuszewska, & Grochowska, 2015) 
Grade 0 No abnormalities (sacroiliac joints normal) 
Grade 1 Suspicious for abnormalities (blurring of the joint margins) 
Grade 2 
Minimal abnormalities (solitary erosions and juxta-articular sclerosis in small sacral or 
iliac areas) 
Grade 3 
Advanced abnormalities (manifested juxta-articular sclerosis, numerous erosions with 
widening of joint space, possible partial ankylosis) 
Grade 4 Complete ankylosis 
 
3. Results 
There was a total of 60 patients who underwent MRE with a final diagnosis of Crohn’s disease, overall 
18 (30%) showed signs of joint inflammation on MRI. of those two patients were symptomatic and 
another two were diagnosed with ankylosing spondylitis as assessed by ASAS criteria (Sieper et al., 
2009).  
Hence, those four patients were excluded, whereas14 patient fulfilled the criteria of having 
asymptomatic SI and Crohn’s disease (23%), with an average age of 36.7, most of them were males 
(71%), Table 4 and Table 5.  
 
Table 4. Characteristics of Patient with Asymptomatic SI and CD 
Age Sex Montreal classification (10) Disease duration (years) 
41 M A2/L1+L4/B2 3 
66 F A3/L1/B1 2 
54 F A2/L3B1 24 
48 F A2/L3/B3 17 
16 M A1/L2/B1 1 
42 M A2/L4/B1 8 
39 M A2/L1/B2 14 
37 M A2/L1/B3p 9 
23 M A2/L1+L4/B3 5 
24 M A2/L1/B1 3 
49 F A3/L2/B1 3 
19 M A2/L3/B2 3 
21 M A2/L3/B1 4 
40 M A2/L2/B2 2 
 
www.scholink.org/ojs/index.php/rhs                   Research in Health Science                         Vol. 4, No. 4, 2019 
310 
Published by SCHOLINK INC. 
Table 5. Demography of 14 Patient Fulfilled the Criteria of Having Asymptomatic SI and Crohn’s 
Disease 
 Male Female Total 
Age range 16-42 48-66 16-66 
Median age 30.2 54.2 37.1 
Number of patients 10 (71%) 4 (29%) 14 (100%) 
Ratio 2.5 1 - 
 
The medications used in these patients including 5-ASA, Azathioprine and Biologics agents are 
detailed in table 6. The percentage of ASA used by patients was 50%, Azathioprine 71%, Biologic 
agents in 36% and single drug was used in 36% of patients. 
 
Table 6. Medications Used by the 14 Patients 
Medications used in 14 patients 
Azathioprine + 5-ASA 5 
 2 
Azathioprine + Adalimumab 3 
Infliximab + 5-ASA 1 





Imaging studies using various modalities (X-ray/CT/MRE) are an integral part of the evaluation and 
management of Crohn’s disease, for assessing disease activity, extent of the disease and complications. 
This approach lead to an increase in the diagnosis of asymptomatic SI in IBD/Crohn’s patient. These 
modalities have different sensitivity and specificity scores. This reflects differences in regional and 
local experience. For example, the rate of detection of asymptomatic SI involvement as assessed by 
plain radiography vary widely from 10 to 27% (McEniff, Eustace, McCarthy, O’Malley, O’Morain, & 
Hamilton, 1995; Queiro, Maiz, Intxausti, de Dios, Belzunegui, González, & Figueroa, 2000; Bandinelli 
et al., 2014). On the other hand, CT scan detection studies were in the range of 13 to 32% (McEniff, 
Eustace, McCarthy, O’Malley, O’Morain, & Hamilton, 1995; Chan, Sari, Salonen, Silverberg, Haroon, 
& Inman, n.d.; Turkcapar et al., 2006).  
Orchard et al. (2009) examined the relationship between MRI findings of SI in patients with established 
Crohn’s disease, in his study 39% of the patients had evidence of SI, of those 35% were asymptomatic. 
In our study most of the patients with asymptomatic sacroiliitis were young males, in contrast to a 
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study by Jacob et al. (2014), in which, most of his patients with sacroiliitis were old females where 
their average age was similar to the average age of the female cases in our study. However, most of 
their patients had symptomatic SI It would be interesting to follow and compare female to male gender 
in regards to future development of frank sacroiliitis. 
A recent study by Girolamo et al. (2018), patients who underwent MRE in an Italian hospital and 
assessed for asymptomatic SI, 35 of 121 (29%) had asymptomatic SI, while the estimated prevalence in 
our study is 23%, this difference can be attributed to the sample size, but not to ethnicity, since both 
study groups are of Mediterranean origin. 
 
5. Conclusion  
Asymptomatic sacroiliitis was detected by MRI in 23% of our patient population with Crohns disease. 
71% were young males. The significance of these finding needs further studies and long term follow up 
to assess the future progression or regression of SI in this patient population and the impact of current 
therapeutic options especially biologics on that. 
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